Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about ARQT
Recent news which mentions ARQT
< Previous
1
2
3
4
Next >
Analyst Expectations for Arcutis Biotherapeutics's Future
June 12, 2023
Tickers
ARQT
Tags
BZI/AAR
Market News
ARQT
From
Benzinga
Why Shares of Arcutis Biotherapeutics Jumped This Week
June 09, 2023
Tickers
ARQT
Tags
ARQT
Market News
Recent Press Releases
From
Motley Fool
7 Short-Interest Stocks to Target for Explosive Gains
May 18, 2023
Tickers
ALLO
ARAV
ARQT
CNK
Tags
NASDAQ:ARAV,NYSE:WWE,NYSE:RVLV,NASDAQ:ALLO,NASDAQ:GALT,NYSE:CNK,NASDAQ:ARQT
ARAV
ARQT
From
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
May 18, 2023
Tickers
AIRS
ARQT
CTLT
HZNP
Tags
CTLT
ARQT
Benzinga
From
Benzinga
The Latest Analyst Ratings for Arcutis Biotherapeutics
May 17, 2023
Tickers
ARQT
Tags
Analyst Ratings
BZI/AAR
ARQT
From
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 10, 2023
Tickers
ARQT
BBLN
CANO
CRVS
Tags
BBLN
RETA
CTKB
From
Benzinga
Arcutis Biotherapeutics: Q1 Earnings Insights
May 09, 2023
Tickers
ARQT
Tags
BZI/Recaps
Benzinga
Earnings
From
Benzinga
Global Payments, MGM Resorts And 3 Stocks To Watch Heading Into Monday
May 01, 2023
Tickers
ARQT
GPN
MGM
ON
Tags
Markets
Market News
News
From
Benzinga
Where Arcutis Biotherapeutics Stands With Analysts
March 29, 2023
Tickers
ARQT
Tags
Analyst Ratings
BZI/AAR
Benzinga
From
Benzinga
Arcutis Biotherapeutics's Earnings Outlook
February 27, 2023
Tickers
ARQT
Tags
BZI/EP
Market News
Benzinga
From
Benzinga
Arcutis' Flagship Psoriasis Treatment Shows Sustained Efficacy, Clearance For Median Of 10 Months
January 17, 2023
Tickers
ARQT
Tags
ARQT
Benzinga
Market News
From
Benzinga
Arcutis Biotherapeutics Stock Surges After Successful Atopic Dermatitis Trial
November 15, 2022
Tickers
ARQT
Tags
Briefs
Biotech
Health Care
From
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 21, 2022
Tickers
ALGN
ARQT
CANO
DXCM
Tags
Market News
Options
MRNA
From
Benzinga
Arcutis Shares Gain On Positive Phase 3 Data On Roflumilast Foam In Scalp, Body Psoriasis
September 26, 2022
Tickers
ARQT
Tags
ARQT
Benzinga
News
From
Benzinga
What 4 Analyst Ratings Have To Say About Arcutis Biotherapeutics
September 22, 2022
Tickers
ARQT
Tags
Benzinga
ARQT
Market News
From
Benzinga
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
Tickers
ADAP
ALLK
ARQT
AZN
Tags
MRK
Health Care
Biotech
From
Benzinga
Atopic Dermatitis Player Arcutis Scoops Up DucentisBioTherapeutics
September 08, 2022
Tickers
ARQT
Tags
News
Benzinga
ARQT
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
September 07, 2022
Tickers
ACCD
ALVO
AMP
AMWL
Tags
CANO
Intraday Update
DCFC
From
Benzinga
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
September 06, 2022
Tickers
AGRI
AMLX
AMPE
APE
Tags
News
LE
HPCO
From
Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 23, 2022
Tickers
AMGN
ARQT
BGNE
BMY
Tags
Benzinga
ARQT
Penny Stocks
From
Benzinga
Arcutis Concludes Dosing In Late-Stage Itchy Skin Study, Anticipates Regulatory Submission By Next Year
August 23, 2022
Tickers
ARQT
Tags
Biotech
General
Health Care
From
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 04, 2022
Tickers
ARQT
ATXS
AZN
MRK
Tags
Market News
MRKR
MRK
From
Benzinga
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday
August 04, 2022
Tickers
AAWW
AHG
AIZ
ALNY
Tags
DUO
FFIE
Market News
From
Benzinga
Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session
August 03, 2022
Tickers
AAWW
AHG
AIZ
ALNY
Tags
CLW
MRNA
IONS
From
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Tickers
ALNY
AMRN
ARQT
BMRN
Tags
Earnings
RGNX
CHRS
From
Benzinga
Analyst Ratings for Arcutis Biotherapeutics
August 02, 2022
Tickers
ARQT
Tags
BZI/AAR
Market News
ARQT
From
Benzinga
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
August 02, 2022
Tickers
AEMD
AJRD
ALRN
AMTD
Tags
News
PKI
ARQT
From
Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
August 01, 2022
Tickers
ALXO
ARQT
AZN
BEAM
Tags
News
HCM
ALXO
From
Benzinga
Recap Of Friday's Biotech Catalysts - End of The Day Summary
July 29, 2022
Tickers
ABBV
ADMP
ARQT
BMY
Tags
Health Care
Biotech
ABBV
From
Benzinga
Arcutis Gets FDA Nod For Plaque Psoriasis Candidate, Sees Commercial Launch In Mid-August
July 29, 2022
Tickers
ARQT
Tags
Market News
General
Biotech
From
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today